Edwards Lifesciences Corporation Cost-method Investments, Other than Temporary Impairment
Edwards Lifesciences Corporation (EW) reported Cost-method Investments, Other than Temporary Impairment of $31.20 million for the 1-month period ending 2017-06-30, per its 10-K filed 2020-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2020-02-14
- Edwards Lifesciences Corporation cost-method investments, other than temporary impairment for the quarter ending 2014-03-31 was $3.50M.
- Edwards Lifesciences Corporation cost-method investments, other than temporary impairment for fiscal 2010 was $3.00M.
| Period end | Cost-method Investments, Other than Temporary Impairment 1 month | Cost-method Investments, Other than Temporary Impairment 3 month | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|---|---|
| 2017-06-30 | $31.20M 10-K · filed 2020-02-14 | ||
| 2014-03-31 | $3.50M 10-Q · filed 2015-10-29 | $3.50M 10-Q · filed 2014-05-02 | |
| 2010-12-31 | $3.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |